Fatty Acid Oxidation in the Pathogenesis of Alzheimer's Disease

This publication has 86 references indexed in Scilit:

• The quest for new cysteinyl-leukotriene and lipoxin receptors: recent clues
  Pharmacology & Therapeutics, 2004
• Neuroinflammation, COX-2, and ALS—a dual role?
  Experimental Neurology, 2004
• Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter
  Experimental Neurology, 2003
• Early Vitamin E supplementation in young but not aged mice reduces Aβ levels and amyloid deposition in a transgenic model of Alzheimer's disease
  The FASEB Journal, 2003
• Phospholipase A2 enzymes
  Prostaglandins & Other Lipid Mediators, 2002
• Effects of reactive γ‐ketoaldehydes formed by the isoprostane pathway (isoketals) and cyclooxygenase pathway (levuglandins) on proteasome function
  The FASEB Journal, 2002
• No difference in plasma or urinary F2-isoprostanes among patients with Huntington's disease or Alzheimer's disease and controls
  Annals of Neurology, 2000
• Deficiency in Mitochondrial Aldehyde Dehydrogenase Increases the Risk for Late-Onset Alzheimer's Disease in the Japanese Population
  Biochemical and Biophysical Research Communications, 2000
• Spin Trapping of Ibuprofen Radicals: Evidence That Ibuprofen is a Hydroxyl Radical Scavenger
  Free Radical Research Communications, 1990
• Docosahexaenoic acid (22:6, n-3) is metabolized to lipoxygenase reaction products in the retina
  Biochemical and Biophysical Research Communications, 1984